Altered GABAA receptor density and unaltered blood–brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis
Studies in rodents suggest that flumazenil is a P-glycoprotein substrate at the blood–brain barrier. This study aimed to assess whether [11C]flumazenil is a P-glycoprotein substrate in humans and to what extent increased P-glycoprotein function in epilepsy may confound interpretation of clinical [11...
Main Authors: | Froklage, Femke E, Postnov, Andrey, Yaqub, Maqsood M, Bakker, Esther, Boellaard, Ronald, Hendrikse, N Harry, Comans, Emile FI, Schuit, Robert C, Schober, Patrick, Velis, Demetrios N, Zwemmer, Jack, Heimans, Jan J, Lammertsma, Adriaan A, Voskuyl, Rob A, Reijneveld, Jaap C |
---|---|
Format: | Online |
Language: | English |
Published: |
SAGE Publications
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167109/ |
Similar Items
-
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
by: Froklage, Femke E, et al.
Published: (2012) -
Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor
by: Palner, Mikael, et al.
Published: (2016) -
Quantification of Dynamic 11C-Phenytoin PET Studies
by: Mansor, Mohd Syahir, et al.
Published: (2015) -
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
by: Cheebsumon, Patsuree, et al.
Published: (2012) -
Gamma oscillations in V1 are correlated with GABAA receptor density: A multi-modal MEG and Flumazenil-PET study
by: Kujala, Jan, et al.
Published: (2015)